Amphastar Pharmaceuticals Price to Free Cash Flow Ratio 2012-2024 | AMPH
Historical price to free cash flow ratio values for Amphastar Pharmaceuticals (AMPH) since 2012.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Amphastar Pharmaceuticals Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2024-12-20 |
39.14 |
|
11.80 |
| 2024-09-30 |
48.53 |
$3.32 |
14.63 |
| 2024-06-30 |
40.00 |
$3.40 |
11.76 |
| 2024-03-31 |
43.91 |
$3.02 |
14.52 |
| 2023-12-31 |
61.85 |
$2.74 |
22.55 |
| 2023-09-30 |
45.99 |
$2.61 |
17.65 |
| 2023-06-30 |
57.47 |
$1.91 |
30.10 |
| 2023-03-31 |
37.50 |
$0.99 |
38.00 |
| 2022-12-31 |
28.02 |
$1.25 |
22.40 |
| 2022-09-30 |
28.10 |
$1.75 |
16.05 |
| 2022-06-30 |
34.79 |
$1.36 |
25.50 |
| 2022-03-31 |
35.90 |
$1.97 |
18.24 |
| 2021-12-31 |
23.29 |
$1.42 |
16.44 |
| 2021-09-30 |
19.01 |
$0.90 |
21.17 |
| 2021-06-30 |
20.16 |
$1.06 |
19.06 |
| 2021-03-31 |
18.32 |
$0.92 |
19.84 |
| 2020-12-31 |
20.11 |
$0.48 |
42.19 |
| 2020-09-30 |
18.75 |
$0.26 |
71.35 |
| 2020-06-30 |
22.46 |
$-0.21 |
0.00 |
| 2020-03-31 |
14.84 |
$0.23 |
64.92 |
| 2019-12-31 |
19.29 |
$0.00 |
0.00 |
| 2019-09-30 |
19.83 |
$0.06 |
355.38 |
| 2019-06-30 |
21.11 |
$0.54 |
38.76 |
| 2019-03-31 |
20.43 |
$-0.46 |
0.00 |
| 2018-12-31 |
19.90 |
$-0.18 |
0.00 |
| 2018-09-30 |
19.24 |
$-0.18 |
0.00 |
| 2018-06-30 |
15.26 |
$-0.45 |
0.00 |
| 2018-03-31 |
18.75 |
$-0.32 |
0.00 |
| 2017-12-31 |
19.24 |
$0.09 |
226.35 |
| 2017-09-30 |
17.87 |
$0.28 |
64.56 |
| 2017-06-30 |
17.86 |
$0.41 |
43.68 |
| 2017-03-31 |
14.50 |
$0.46 |
31.30 |
| 2016-12-31 |
18.42 |
$0.36 |
50.94 |
| 2016-09-30 |
18.97 |
$0.16 |
119.99 |
| 2016-06-30 |
16.12 |
$0.20 |
81.46 |
| 2016-03-31 |
12.00 |
$0.16 |
75.61 |
| 2015-12-31 |
14.23 |
$-0.12 |
0.00 |
| 2015-09-30 |
11.69 |
$-0.02 |
0.00 |
| 2015-06-30 |
17.58 |
$0.24 |
73.10 |
| 2015-03-31 |
14.96 |
$-0.05 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.894B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
